Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis. [electronic resource]
Producer: 20111007Description: 631-9 p. digitalISSN:- 1524-4733
- Acetamides -- economics
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Infective Agents -- economics
- Bayes Theorem
- Cost-Benefit Analysis
- Daptomycin -- economics
- Decision Support Techniques
- Diagnostic Tests, Routine -- economics
- Drug Costs
- Drug Therapy, Combination
- Health Services Research
- Hospital Costs
- Humans
- Linezolid
- Methicillin-Resistant Staphylococcus aureus -- pathogenicity
- Middle Aged
- Models, Economic
- Outcome and Process Assessment, Health Care -- economics
- Oxazolidinones -- economics
- Staphylococcal Skin Infections -- diagnosis
- Treatment Outcome
- United States
- Vancomycin -- economics
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.